0      0

W103d - Establishing Patient-centric Quality Standards: Cell & Gene Therapy Case Studies

‐ May 13, 2020 3:35pm

Patient-centric quality standards are a key component of ensuring patient access to safe and efficacious cell and gene therapies. Two case studies relevant to ex vivo autologous T cell therapeutics will be presented, together highlighting how the identification of product-relevant attributes and understanding of clinical exposure range can factor into product specification setting.


You must be logged in and own this session in order to post comments.